Transcriptional effects include expression of erythropoietin, resulting in polycythemia, and vascular endothelial growth factor (VEGF), contributing to a pro-angiogenic phenotype, and resulting in decreased expression of PNMT, characteristic of cluster 1 mutations (41, 55). Here, VEGFA is linked to polycythemia.